Zarife Sahenk, MD, PhD

Zarife Sahenk, MD, PhD, is an attending neurologist at Nationwide Children’s, Director of Clinical and Experimental Neuromuscular Pathology at The Research Institute at Nationwide Children's and Professor of Pediatrics, Pathology and Neurology at The Ohio State University College of Medicine. Her research aims to define the anatomical and molecular basis of hereditary peripheral neuropathies, emphasizing the role of trophic factors secreted by Schwann cells in regeneration-associated myelination. The role of neurotrophin-3 in nerve regeneration in patients and animal models of Charcot-Marie-Tooth (CMT) is currently under investigation. These studies are relevant to understanding the mechanism of axonal loss and impaired regeneration in CMT disorders and developing rational therapies to promote nerve repair.

Gender:

• Female

Languages Spoken:

• English

Research Center:

• Center for Gene Therapy

Areas of Interest:

• A primary goal of Dr. Sahenk's research program is to gain a detailed understanding of the anatomical and molecular basis of hereditary peripheral neuropathies. Particular emphasis is placed on the role of trophic factors secreted by Schwann cells in regeneration-associated myelination. The role of neurotrophin-3 in nerve regeneration in patients and animal models of Charcot-Marie-Tooth (CMT) is currently being investigated. These studies are relevant to understanding the mechanism of axonal loss and impaired regeneration in CMT disorders and developing rational therapies to promote nerve repair.

Research Funding*:

• Evaluating the Potential Efficacy of trkB, trkC Receptor Agonists and Their Combination in a Mouse Model of Charcot-Marie-Tooth Disease, Anonymous

Internship

• Hacettepe University
  Date Completed: 06/30/1972

Medical School

• Hacettepe University
  Date Completed: 07/31/1972

Residency

• Hacettepe University
  Date Completed: 09/30/1972

Residency

• Ohio State University Medical Center
  Date Completed: 06/30/1975

Fellowship

• Ohio State University Medical Center
  Date Completed: 06/30/1978

Post Doctoral

• The Ohio State University
  Date Completed: 06/30/1998

Department:

• Pediatrics

Section:

• Neurology

Speciality:

• Neurology, Certified
  

Date of Appointment at Children's Hospital:

• 06/30/2005

2005–present

• Professor of Neurology and Pediatrics, The Research Institute at Nationwide Children's Hospital, Neuromuscular Program, Director, Neuromuscular Pathology

1999–present

• Professor of Neurology, Department of Neurology, Ohio State University College of Medicine

1999–2005

• Director of the Clinical and Experimental Neuromuscular Disease Laboratories, Division of Neuromuscular Disease, Department of Neurology, Ohio State University Hospitals

1986–1987

• Visiting Scientist, Bio-Architectonics Center, Case Western Reserve University, Cleveland, Ohio

1983–1999

• Associate Professor or Neurology, Department of Neurology, Ohio State University College of Medicine

1978–1983

• Assistant Professor, Department of Neurology, Ohio State University College of Medicine

• Sahenk Z; Mendell JR. 2011. The muscular dystrophies: distinct pathogenic mechanisms invite novel therapeutic approaches.  Current Rheumatology Reports. Vol. 13, no. 3. (June 1): 199.
• Gladman JT; Bebee TW; Edwards C; Wang X; Sahenk Z; Rich MM; Chandler DS. 2010. A humanized Smn gene containing the SMN2 nucleotide alteration in exon 7 mimics SMN2 splicing and the SMA disease phenotype.  Human Molecular Genetics. Vol. 19, no. 21. (November 1): 4239.
• Mendell JR; Rodino-Klapac LR; Rosales XQ; Coley BD; Galloway G; Lewis S; Malik V; Shilling C; Byrne BJ; Conlon T; Campbell KJ; Bremer WG; Taylor LE; Flanigan KM; Gastier-Foster JM; Astbury C; Kota J; Sahenk Z; Walker CM; Clark KR. 2010. Sustained alpha-sarcoglycan gene expression after gene transfer in limb-girdle muscular dystrophy, type 2D.  Annals Of Neurology. Vol. 68, no. 5. (November 1): 629.
• Mendell JR; Campbell K; Rodino-Klapac L; Sahenk Z; Shilling C; Lewis S; Bowles D; Gray S; Li C; Galloway G; Malik V; Coley B; Clark KR; Li J; Xiao X; Samulski J; McPhee SW; Samulski RJ; Walker CM. 2010. Dystrophin immunity in Duchenne's muscular dystrophy.  The New England Journal Of Medicine. Vol. 363, no. 15. (October 7): 1429.
• Sahenk Z; Galloway G; Edwards C; Malik V; Kaspar BK; Eagle A; Yetter B; Forgie A; Tsao D; Lin JC. 2010. TrkB and TrkC agonist antibodies improve function, electrophysiologic and pathologic features in Trembler J mice.  Experimental Neurology. Vol. 224, no. 2. (August 1): 495.
• Rosales XQ; Gastier-Foster JM; Lewis S; Vinod M; Thrush DL; Astbury C; Pyatt R; Reshmi S; Sahenk Z; Mendell JR. 2010. Novel diagnostic features of dysferlinopathies.  Muscle & Nerve. Vol. 42, no. 1. (July 1): 14.
• Collins MP; Periquet-Collins I; Sahenk Z; Kissel JT. 2010. Direct immunofluoresence in vasculitic neuropathy: specificity of vascular immune deposits.  Muscle & Nerve. Vol. 42, no. 1. (July 1): 62.
• Malik V; Rodino-Klapac LR; Viollet L; Wall C; King W; Al-Dahhak R; Lewis S; Shilling CJ; Kota J; Serrano-Munuera C; Hayes J; Mahan JD; Campbell KJ; Banwell B; Dasouki M; Watts V; Sivakumar K; Bien-Willner R; Flanigan KM; Sahenk Z; Barohn RJ; Walker CM; Mendell JR. 2010. Gentamicin-induced readthrough of stop codons in Duchenne muscular dystrophy.  Annals Of Neurology. Vol. 67, no. 6 (June 1): 771.
• Rodino-Klapac LR; Montgomery CL; Bremer WG; Shontz KM; Malik V; Davis N; Sprinkle S; Campbell KJ; Sahenk Z; Clark KR; Walker CM; Mendell JR; Chicoine LG. 2010. Persistent expression of FLAG-tagged micro dystrophin in nonhuman primates following intramuscular and vascular delivery.  Molecular Therapy: The Journal Of The American Society Of Gene Therapy. Vol. 18, no. 1 (January 1): 109.
• Kota J; Handy CR; Haidet AM; Montgomery CL; Eagle A; Rodino-Klapac LR; Tucker D; Shilling CJ; Therlfall WR; Walker CM; Weisbrode SE; Janssen PM; Clark KR; Sahenk Z; Mendell JR; Kaspar BK. 2009. Follistatin gene delivery enhances muscle growth and strength in nonhuman primates.  Science Translational Medicine. Vol. 1, no. 6 (November 11): 6ra15.
• Mendell JR; Rodino-Klapac LR; Rosales-Quintero X; Kota J; Coley BD; Galloway G; Craenen JM; Lewis S; Malik V; Shilling C; Byrne BJ; Conlon T; Campbell KJ; Bremer WG; Viollet L; Walker CM; Sahenk Z; Clark KR. 2009. Limb-girdle muscular dystrophy type 2D gene therapy restores alpha-sarcoglycan and associated proteins.  Annals Of Neurology. Vol. 66, no. 3 (September 1): 290.
• Martin PT, Xu R, Rodino-Klapac LR, Oglesbay E, Camboni M, Montgomery CL, Shontz K, Chicoine L, Clark KR, Sahenk Z, Mendell JR, Janssen PM. 2008. Overexpression of Galgt2 in skeletal muscle prevents injury resulting from eccentric contractions in both mdx and wild type mice. Am J Physiol Cell Physiol, no. Epub. (December 24). (IF: 4.230)
• Tsao CY, Mendell J, Sahenk Z, Rusin J, Boue D. 2008. Hypotonia, weakness, and pontocerebellar hypoplasia in siblings. Semin Pediatr Neurol.. Vol. 15, no. 4. (December): 151-153.
• Sahenk Z, Oblinger J, Edwards C. 2008. Neurotrophin-3 deficient Schwann cells impair nerve regeneration. Exp Neurol.. Vol. 221, no. 2. (August): 552-556. (IF: 3.982)
• Zhang X, Chow CY, Sahenk Z, Shy ME, Meisler MH, Li J. 2008. Mutation of FIG4 causes a rapidly progressive, asymmetric neuronal degeneration. Brain.. Vol. 131, no. Pt 8. (August): 1990-2001. (IF: 8.568)
• Haidet AM, Rizo L, Handy C, Umapathi P, Eagle A, Shilling C, Boue D, Martin PT, Sahenk Z, Mendell JR, Kaspar BK. 2008. Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors. Proc Natl Acad Sci USA.. Vol. 105, no. 11. (March): 4318-4322.
• Acharyya S, Villalta SA, Bakkar N, Bupha-Intr T, Janssen PM, Carathers M, Li ZW, Beg AA, Ghosh S, Sahenk Z, Weinstein M, Gardner KL, Rafael-Fortney JA, Karin M, Tidball JG, Baldwin AS, Guttridge DC. 2007. Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy. Journal of Clinical Investigation. Vol. 117, no. 4: 889-901.
• Sahenk, Zarife. 2006. Neurotrophins and peripheral neuropathies. Brain pathology (Zurich, Switzerland). Vol. 16, no. 4: 311-9.
• Acharyya, Swarnali; Butchbach, Matthew E, R; Sahenk, Zarife; Wang, Huating; Saji, Motoyasu; Carathers, Micheal; Ringel, Matthew, D; Skipworth, Richard J, E; Fearon, Kenneth C, H; Hollingsworth, Michael, A; Muscarella, Peter; Burghes, Arthur H, M; Rafael-Fortney, Jill, A; Guttridge, Denis C. 2005. Dystrophin glycoprotein complex dysfunction: a regulatory link between muscular dystrophy and cancer cachexia. Cancer cell. Vol. 8, no. 5: 421-32.
• Sahenk, Z; Nagaraja, H, N; McCracken, B, S; King, W, M; Freimer, M, L; Cedarbaum, J, M; Mendell, J R. 2005. NT-3 promotes nerve regeneration and sensory improvement in CMT1A mouse models and in patients. Neurology. Vol. 65, no. 5: 681-9.
• Mendell, Jerry, R; Sahenk, Zarife. 2003. Clinical practice. Painful sensory neuropathy. The New England journal of medicine. Vol. 348, no. 13: 1243-55.
• Abrams, Charles, K; Freidin, Mona; Bukauskas, Feliksas; Dobrenis, Kostantin; Bargiello, Thaddeus, A; Verselis, Vytas, K; Bennett, Michael V, L; Chen, Lei; Sahenk, Zarife. 2003. Pathogenesis of X-linked Charcot-Marie-Tooth disease: differential effects of two mutations in connexin 32. The Journal of neuroscience : the official journal of the Society for Neuroscience. Vol. 23, no. 33: 10548-58.
• Sahenk, Zarife; Serrano-Munuera, Carmen; Chen, Lei; Kakabadze, Inga; Najagara, Haikady N. 2003. Evidence for impaired axonal regeneration in PMP22 duplication: studies in nerve xenografts. Journal of the peripheral nervous system : JPNS. Vol. 8, no. 2: 116-27.
• Collins, M, P; Periquet, M, I; Mendell, J, R; Sahenk, Z; Nagaraja, H, N; Kissel, J T. 2003. Nonsystemic vasculitic neuropathy: insights from a clinical cohort. Neurology. Vol. 61, no. 5: 623-30.
• Novak, V; Freimer, M, L; Kissel, J, T; Sahenk, Z; Periquet, I, M; Nash, S, M; Collins, M, P; Mendell, J R. 2001. Autonomic impairment in painful neuropathy. Neurology. Vol. 56, no. 7: 861-8.
• Feng, B; Chen, L; Drmanovic, Z; Kakabadze, I; Mendell, J, R; Marzluf, G, A; Sahenk, Z. 2000. Intracellular processing and toxicity of the truncated androgen receptor: nuclear congophilia-associated cell death. Journal of neuropathology and experimental neurology. Vol. 59, no. 8: 652-63.
• Collins, M, P; Mendell, J, R; Periquet, M, I; Sahenk, Z; Amato, A, A; Gronseth, G, S; Barohn, R, J; Jackson, C, E; Kissel, J T. 2000. Superficial peroneal nerve/peroneus brevis muscle biopsy in vasculitic neuropathy. Neurology. Vol. 55, no. 5: 636-43.
• Sahenk, Z; Mendell, J R. 1999. Alterations in nodes of Ranvier and Schmidt-Lanterman incisures in Charcot-Marie-Tooth neuropathies. Annals of the New York Academy of Sciences. Vol. 883: 508-12.
• Sahenk, Z. 1999. Abnormal Schwann cell-axon interactions in CMT neuropathies. The effects of mutant Schwann cells on the axonal cytoskeleton and regeneration-associated myelination. Annals of the New York Academy of Sciences. Vol. 883: 415-26.
• Sahenk, Z; Chen, L; Mendell, J R. 1999. Effects of PMP22 duplication and deletions on the axonal cytoskeleton. Annals of neurology. Vol. 45, no. 1: 16-24.
• Periquet, M, I; Novak, V; Collins, M, P; Nagaraja, H, N; Erdem, S; Nash, S, M; Freimer, M, L; Sahenk, Z; Kissel, J, T; Mendell, J R. 1999. Painful sensory neuropathy: prospective evaluation using skin biopsy. Neurology. Vol. 53, no. 8: 1641-7.
• Haney, C, A; Sahenk, Z; Li, C; Lemmon, V, P; Roder, J; Trapp, B D. 1999. Heterophilic binding of L1 on unmyelinated sensory axons mediates Schwann cell adhesion and is required for axonal survival. The Journal of cell biology. Vol. 146, no. 5: 1173-84.
• Mendell, J, T; Panicker, S, G; Tsao, C, Y; Feng, B; Sahenk, Z; Marzluf, G, A; Mendell, J R. 1998. Novel compound heterozygous laminina2-chain gene (LAMA2) mutations in congenital muscular dystrophy. Mutations in brief no. 159. Online. Human mutation. Vol. 12, no. 2: 135.
• Erdem, S; Mendell, J, R; Sahenk, Z. 1998. Fate of Schwann cells in CMT1A and HNPP: evidence for apoptosis. Journal of neuropathology and experimental neurology. Vol. 57, no. 6: 635-42.
• Working, P, K; Newman, M, S; Sullivan, T; Brunner, M; Podell, M; Sahenk, Z; Turner, N. 1998. Comparative intravenous toxicity of cisplatin solution and cisplatin encapsulated in long-circulating, pegylated liposomes in cynomolgus monkeys. Toxicological sciences : an official journal of the Society of Toxicology. Vol. 46, no. 1: 155-65.
• Sahenk, Z; Chen, L; Freimer, M. 1998. A novel PMP22 point mutation causing HNPP phenotype: studies on nerve xenografts. Neurology. Vol. 51, no. 3: 702-7.
• Sahenk, Z; Chen, L. 1998. Abnormalities in the axonal cytoskeleton induced by a connexin32 mutation in nerve xenografts. Journal of neuroscience research. Vol. 51, no. 2: 174-84.
• Mendell, J, R; Sahenk, Z; Prior, T W. 1995. The childhood muscular dystrophies: diseases sharing a common pathogenesis of membrane instability. Journal of child neurology. Vol. 10, no. 2: 150-9.
• Barohn, R, J; Amato, A, A; Sahenk, Z; Kissel, J, T; Mendell, J R. 1995. Inclusion body myositis: explanation for poor response to immunosuppressive therapy. Neurology. Vol. 45, no. 7: 1302-4.
• Mendell, J, R; Kissel, J, T; Amato, A, A; King, W; Signore, L; Prior, T, W; Sahenk, Z; Benson, S; McAndrew, P, E; Rice, R. 1995. Myoblast transfer in the treatment of Duchenne's muscular dystrophy. The New England journal of medicine. Vol. 333, no. 13: 832-8.
• Tan, E; Lynn, D, J; Amato, A, A; Kissel, J, T; Rammohan, K, W; Sahenk, Z; Warmolts, J, R; Jackson, C, E; Barohn, R, J; Mendell, J R. 1994. Immunosuppressive treatment of motor neuron syndromes. Attempts to distinguish a treatable disorder. Archives of neurology. Vol. 51, no. 2: 194-200.
• Sahenk, Z; Seharaseyon, J; Mendell, J R. 1994. CNTF potentiates peripheral nerve regeneration. Brain research. Vol. 655, no. 1-2: 246-50.
• Amato, A, A; Barohn, R, J; Jackson, C, E; Pappert, E, J; Sahenk, Z; Kissel, J T. 1994. Inclusion body myositis: treatment with intravenous immunoglobulin. Neurology. Vol. 44, no. 8: 1516-8.
• Sahenk, Z; Barohn, R; New, P; Mendell, J R. 1994. Taxol neuropathy. Electrodiagnostic and sural nerve biopsy findings. Archives of neurology. Vol. 51, no. 7: 726-9.
• Amato, A, A; Barohn, R, J; Sahenk, Z; Tutschka, P, J; Mendell, J R. 1993. Polyneuropathy complicating bone marrow and solid organ transplantation. Neurology. Vol. 43, no. 8: 1513-8.
• Sahenk, Z; Seharaseyon, J; Mendell, J, R; Burghes, A H. 1993. Gene delivery to spinal motor neurons. Brain research. Vol. 606, no. 1: 126-9.
• Mendell, J, R; Sahenk, Z. 1992. Inclusion body myositis. Neurology. Vol. 42, no. 11: 2231-2.
• Sahenk, Z; Mendell, J R. 1992. Alterations in slow transport kinetics induced by estramustine phosphate, an agent binding to microtubule-associated proteins. Journal of neuroscience research. Vol. 32, no. 4: 481-93.
• Barohn, R, J; Sahenk, Z; Warmolts, J, R; Mendell, J R. 1991. The Bruns-Garland syndrome (diabetic amyotrophy). Revisited 100 years later. Archives of neurology. Vol. 48, no. 11: 1130-5.
• Mendell, J, R; Sahenk, Z; Gales, T; Paul, L. 1991. Amyloid filaments in inclusion body myositis. Novel findings provide insight into nature of filaments. Archives of neurology. Vol. 48, no. 12: 1229-34.
• Sahenk, Z; Brown, A. 1991. Weak-base amines inhibit the anterograde-to-retrograde conversion of axonally transported vesicles in nerve terminals. Journal of neurocytology. Vol. 20, no. 5: 365-75.
• Barohn, R, J; Clanton, T; Sahenk, Z; Mendell, J R. 1990. Recurrent respiratory insufficiency and depressed ventilatory drive complicating mitochondrial myopathies. Neurology. Vol. 40, no. 1: 103-6.
• Sahenk, Z. 1990. Distal terminal axonopathy produced by 2,4-dithiobiuret: effects of long-term intoxication in rats. Acta neuropathologica. Vol. 81, no. 2: 141-7.
• Sahenk, Z; Whitaker, J, N; Mendell, J R. 1990. Immunocytochemical evidence for the retrograde transport of intraaxonal cathepsin D: possible relevance to the dying-back process. Brain research. Vol. 510, no. 1: 1-6.
• Sahenk, Z; Lasek, R J. 1988. Inhibition of proteolysis blocks anterograde-retrograde conversion of axonally transported vesicles. Brain research. Vol. 460, no. 1: 199-203.
• Ross, J, F; Sahenk, Z; Hyser, C; Mendell, J, R; Alden, C L. 1988. Characterization of a murine model for human bismuth encephalopathy. Neurotoxicology. Vol. 9, no. 4: 581-6.
• Pappolla, M; Penton, R; Weiss, H, S; Miller, C H Jr; Sahenk, Z; Autilio-Gambetti, L; Gambetti, P. 1987. Carbon disulfide axonopathy. Another experimental model characterized by acceleration of neurofilament transport and distinct changes of axonal size. Brain research. Vol. 424, no. 2: 272-80.
• Sahenk, Z. 1987. Toxic neuropathies. Seminars in neurology. Vol. 7, no. 1: 9-17.
• Sahenk, Z; Brady, S T. 1987. Axonal tubulin and microtubules: morphologic evidence for stable regions on axonal microtubules. Cell motility and the cytoskeleton. Vol. 8, no. 2: 155-64.
• Sahenk, Z; Brady, S, T; Mendell, J R. 1987. Studies on the pathogenesis of vincristine-induced neuropathy. Muscle & nerve. Vol. 10, no. 1: 80-4.
• Mendell, J, R; Kissel, J, T; Kennedy, M, S; Sahenk, Z; Grinvalsky, H, T; Pittman, G, L; Kyler, R, S; Roelofs, R, I; Whitaker, J, N; Bertorini, T E. 1985. Plasma exchange and prednisone in Guillain-Barre syndrome: a controlled randomized trial. Neurology. Vol. 35, no. 11: 1551-5.
• Mendell, J, R; Sahenk, Z; Whitaker, J, N; Trapp, B, D; Yates, A, J; Griggs, R, C; Quarles, R H. 1985. Polyneuropathy and IgM monoclonal gammopathy: studies on the pathogenetic role of anti-myelin-associated glycoprotein antibody. Annals of neurology. Vol. 17, no. 3: 243-54.
• Mendell, J, R; Kissel, J, T; Kennedy, M, S; Sahenk, Z; Grinvalsky, H, T; Pittman, G, L; Kyler, R, S; Roelofs, R, I; Whitaker, J, N; Bertorini, T E. 1985. Plasma exchange and prednisone in acute inflammatory polyradiculoneuropathy: a controlled randomized trial. Journal of clinical apheresis. Vol. 2, no. 4: 332-42.
• Whitaker, J, N; Dodd, S, P; Sahenk, Z; Mendell, J R. 1983. Changes in sciatic nerve cathepsin D after ligation or exposure to neurotoxins. Journal of neuropathology and experimental neurology. Vol. 42, no. 1: 87-98.
• Ortman, J, A; Sahenk, Z; Mendell, J R. 1983. The experimental production of Renaut bodies. Journal of the neurological sciences. Vol. 62, no. 1-3: 233-41.
• Sahenk, Z; Mendell, J R. 1983. Studies on the morphologic alterations of axonal membraneous organelles in neurofilamentous neuropathies. Brain research. Vol. 268, no. 2: 239-47.
• Mendell, J, R; Sahenk, Z; Warmolts, J, R; Marshall, J, K; Thibert, P. 1981. The spontaneously diabetic BB Wistar rat. Morphologic and physiologic studies of peripheral nerve. Journal of the neurological sciences. Vol. 52, no. 1: 103-15.
• Sahenk, Z; Mendell, J R. 1981. Acrylamide and 2,5-hexanedione neuropathies: abnormal bidirectional transport rate in distal axons. Brain research. Vol. 219, no. 2: 397-405.
• DiMauro, S; Mendell, J, R; Sahenk, Z; Bachman, D; Scarpa, A; Scofield, R, M; Reiner, C. 1980. Fatal infantile mitochondrial myopathy and renal dysfunction due to cytochrome-c-oxidase deficiency. Neurology. Vol. 30, no. 8: 795-804.
• Sahenk, Z; Mendell, J R. 1980. Axoplasmic transport in zinc pyridinethione neuropathy: evidence for an abnormality in distal turn-around. Brain research. Vol. 186, no. 2: 343-53.
• Sahenk, Z; Mendell, J R. 1979. Ultrastructural study of zinc pyridinethione-induced peripheral neuropathy. Journal of neuropathology and experimental neurology. Vol. 38, no. 5: 532-50.
• Mendell, J, R; Higgins, R; Sahenk, Z; Cosmos, E. 1979. Relevance of genetic animal models of muscular dystrophy to human muscular dystrophies. Annals of the New York Academy of Sciences. Vol. 317: 409-30.
• Sahenk, Z; Mendell, J R. 1979. Analysis of fast axoplasmic transport in nerve ligation and adriamycin-induced neuronal perikaryon lesions. Brain research. Vol. 171, no. 1: 41-53.
• Sahenk, Z; Mendell, J, R; Couri, D; Nachtman, J. 1978. Polyneuropathy from inhalation of N2O cartridges through a whipped-cream dispenser. Neurology. Vol. 28, no. 5: 485-7.
• Saida, K; Mendell, J, R; Sahenk, Z. 1977. Peripheral nerve changes induced by local application of bee venom. Journal of neuropathology and experimental neurology. Vol. 36, no. 5: 783-96.
• Sahenk, Z; Mendell, J, R; Rossio, J, L; Hurtubise, P. 1977. Polyradiculoneuropathy accompanying procainamide-induced lupus erythematosus: evidence for drug-induced enhanced sensitization to peripheral nerve myelin. Annals of neurology. Vol. 1, no. 4: 378-84.
• Mendell, J, R; Sahenk, Z; Saida, K; Weiss, H, S; Savage, R; Couri, D. 1977. Alterations of fast axoplasmic transport in experimental methyl n-butyl ketone neuropathy. Brain research. Vol. 133, no. 1: 107-18.
• Silverman, L, M; Mendell, J, R; Sahenk, Z; Fontana, M B. 1976. Significance of creatine phosphokinase isoenzymes in Duchenne dystrophy. Neurology. Vol. 26, no. 6 PT 1: 561-4.